159 related articles for article (PubMed ID: 34418466)
21. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
22. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
[TBL] [Abstract][Full Text] [Related]
23. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT.
Lee TF; Ting HM; Chao PJ; Fang FM
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):196-207. PubMed ID: 21752615
[TBL] [Abstract][Full Text] [Related]
24. Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.
White P; Chan KC; Cheng KW; Chan KY; Chau MC
J Radiat Res; 2013 May; 54(3):532-45. PubMed ID: 23188186
[TBL] [Abstract][Full Text] [Related]
25. [Feasibility of Automatic Treatment Planning in Intensity-modulated Radiotherapy of Nasopharyngeal Carcinoma].
He Y; Zhang L; Xiao J; Duan B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Dec; 32(6):1288-93. PubMed ID: 27079103
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
27. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.
Yan D; Yan S; Wang Q; Liao X; Lu Z; Wang Y
BMC Cancer; 2013 Nov; 13():548. PubMed ID: 24237861
[TBL] [Abstract][Full Text] [Related]
28. Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Qu S; Liang ZG; Zhu XD
Asian Pac J Cancer Prev; 2015; 16(5):1687-92. PubMed ID: 25773811
[TBL] [Abstract][Full Text] [Related]
29. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
Müller RP; Eich HT
Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
[TBL] [Abstract][Full Text] [Related]
30. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
32. A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy.
Bai P; Weng X; Quan K; Chen J; Dai Y; Xu Y; Lin F; Zhong J; Wu T; Chen C
Radiat Oncol; 2020 Aug; 15(1):188. PubMed ID: 32746873
[TBL] [Abstract][Full Text] [Related]
33. Multi-institutional comparison of intensity modulated radiation therapy (IMRT) planning strategies and planning results for nasopharyngeal cancer.
Park SH; Park HC; Park SW; Oh DH; Choi Y; Kim JK; Ahn YC; Park W; Suh HS; Lee R; Bae H
J Korean Med Sci; 2009 Apr; 24(2):248-55. PubMed ID: 19399266
[TBL] [Abstract][Full Text] [Related]
34. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X; Wei Y; Tao H; Zhu J; Li B
Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
[TBL] [Abstract][Full Text] [Related]
35. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M; Zilli T; Dubouloz A; Escude L; Jorcano S; Linthout N; Bral S; Verbakel W; Bruynzeel A; Björkqvist M; Minn H; Tsvang L; Symon Z; Lencart J; Oliveira A; Ozen Z; Abacioglu U; Pérez-Moreno JM; Rubio C; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1047-1054. PubMed ID: 32535161
[TBL] [Abstract][Full Text] [Related]
36. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
37. SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.
Gao J; Qian TL; Tao CZ; Zhang YH; Zhou Y; Yang J; He J; Wang R; Zhou PJ
Br J Radiol; 2015 Sep; 88(1053):20150052. PubMed ID: 26111068
[TBL] [Abstract][Full Text] [Related]
38. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
Peng G; Wang T; Yang KY; Zhang S; Zhang T; Li Q; Han J; Wu G
Radiother Oncol; 2012 Sep; 104(3):286-93. PubMed ID: 22995588
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.
Guo R; Tang LL; Mao YP; Zhou GQ; Qi ZY; Liu LZ; Lin AH; Liu MZ; Ma J; Sun Y
PLoS One; 2015; 10(7):e0129679. PubMed ID: 26146828
[TBL] [Abstract][Full Text] [Related]
40. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
